Home LiteratureArticle Details
PMID: 7739569 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin.

Molecular and cellular biology ·Vol. 15 ·No. 5 ·1995-05-00 ·Pages 2893-903

Little RD, Schildkraut CL

Abstract

Our laboratory has previously shown that replication of a small plasmid, p174, containing the genetically defined Epstein-Barr virus (EBV) latent origin of replication, oriP, initiates within oriP at or near a dyad symmetry (DS) element and terminates specifically at a family of repeated sequences (FR), also located within oriP. We describe here an analysis of the replication of intact approximately 170-kb EBV genomes in four latently infected cell lines that uses two-dimensional gel replicon mapping. Initiation was detected at oriP in all EBV genomes examined; however, some replication forks appear to originate from alternative initiation sites. In addition, pausing of replication forks was observed at the two clusters of EBV nuclear antigen 1 binding sites within oriP and at or near two highly expressed viral genes 0.5 to 1 kb upstream of oriP, the EBV-encoded RNA (EBER) genes. In the Raji EBV genome, the relative abundance of these stalled forks and the direction in which they are stalled indicate that most replication forks originate upstream of oriP. We thus searched for additional initiation sites in the Raji EBV and found that the majority of initiation events were distributed over a broad region to the left of oriP. This delocalized pattern of initiation resembles initiation of replication in several well-characterized mammalian chromosomal loci and is the first described for any viral genome. EBV thus provides a unique model system with which to investigate factors influencing the selection of replication initiation and termination sites in mammalian cells.

MeSH Terms
Antigens, Viral/metabolism Base Sequence Cell Line, Transformed Cell Transformation, Viral/genetics Chromosome Mapping DNA Replication/genetics DNA, Viral/genetics DNA-Binding Proteins/metabolism Epstein-Barr Virus Nuclear Antigens Genome, Viral Herpesvirus 4, Human/genetics,immunology,physiology Humans Molecular Sequence Data Plasmids/genetics Replication Origin Virus Replication/genetics
Chemicals
Antigens, Viral DNA, Viral DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Little R D
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Schildkraut C L
References (65)
65 references, click to expand
  1. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.
    J Virol. 1984 Apr;50(1):248-54 PMID: 6321792
  2. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.
    EMBO J. 1984 Apr;3(4):813-21 PMID: 6327290
  3. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
    Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10 PMID: 6328526
  4. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  5. Electron microscopic evidence for replication of circular Epstein-Barr virus genomes in latently infected Raji cells.
    J Virol. 1984 Nov;52(2):549-56 PMID: 6092676
  6. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  7. Chromatin structure of Epstein-Barr virus.
    J Gen Virol. 1985 Sep;66 ( Pt 9):1931-40 PMID: 2993484
  8. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.
    Cell. 1985 Oct;42(3):859-68 PMID: 2996781
  9. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
    Mol Cell Biol. 1985 Aug;5(8):1822-32 PMID: 3018528
  10. Significant potential secondary structures in the Epstein-Barr virus genome.
    Proc Natl Acad Sci U S A. 1986 Sep;83(18):6915-9 PMID: 3018750
  11. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Mol Cell Biol. 1986 Nov;6(11):3838-46 PMID: 3025615
  12. Replication of latent Epstein-Barr virus genomes in Raji cells.
    J Virol. 1987 May;61(5):1743-6 PMID: 3033303
  13. The localization of replication origins on ARS plasmids in S. cerevisiae.
    Cell. 1987 Nov 6;51(3):463-71 PMID: 2822257
  14. Sequence analysis of Raji Epstein-Barr virus DNA.
    Virology. 1988 Jun;164(2):334-40 PMID: 2835854
  15. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Cell. 1988 Nov 4;55(3):427-33 PMID: 2846181
  16. A replication fork barrier at the 3' end of yeast ribosomal RNA genes.
    Cell. 1988 Nov 18;55(4):637-43 PMID: 3052854
  17. Organization of replication of ribosomal DNA in Saccharomyces cerevisiae.
    Mol Cell Biol. 1988 Nov;8(11):4927-35 PMID: 3062373
  18. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements.
    Cell. 1989 Jun 2;57(5):825-34 PMID: 2541926
  19. Isolation of human sequences that replicate autonomously in human cells.
    Mol Cell Biol. 1989 Mar;9(3):1026-33 PMID: 2542763
  20. Viral latency and transformation: the strategy of Epstein-Barr virus.
    Cell. 1989 Jul 14;58(1):5-8 PMID: 2546674
  21. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Cell. 1989 Aug 11;58(3):527-35 PMID: 2547525
  22. Relative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt.
    J Virol. 1989 Nov;63(11):4938-44 PMID: 2552173
  23. The replication terminator protein of E. coli is a DNA sequence-specific contra-helicase.
    Cell. 1989 Nov 17;59(4):667-74 PMID: 2684415
  24. EBV gene expression in an NPC-related tumour.
    EMBO J. 1989 Sep;8(9):2639-51 PMID: 2479554
  25. Escherichia coli replication termination protein impedes the action of helicases.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9104-8 PMID: 2556700
  26. The switch between latency and replication of Epstein-Barr virus.
    J Infect Dis. 1990 May;161(5):833-44 PMID: 2157769
  27. Replication initiates in a broad zone in the amplified CHO dihydrofolate reductase domain.
    Cell. 1990 Jun 15;61(6):1075-87 PMID: 2350784
  28. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.
    Virology. 1990 Nov;179(1):339-46 PMID: 2171209
  29. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.
    J Virol. 1991 Jan;65(1):483-8 PMID: 1845903
  30. Replication initiates at multiple locations on an autonomously replicating plasmid in human cells.
    Mol Cell Biol. 1991 Mar;11(3):1464-72 PMID: 1996103
  31. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50 PMID: 1847527
  32. Autonomous DNA replication in human cells is affected by the size and the source of the DNA.
    Mol Cell Biol. 1991 Apr;11(4):2263-72 PMID: 1900922
  33. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus.
    J Biol Chem. 1991 Apr 25;266(12):7819-26 PMID: 1850421
  34. Mapping of replication initiation sites in mammalian genomes by two-dimensional gel analysis: stabilization and enrichment of replication intermediates by isolation on the nuclear matrix.
    Mol Cell Biol. 1991 Aug;11(8):3850-9 PMID: 2072896
  35. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
    J Gen Virol. 1991 Jul;72 ( Pt 7):1591-9 PMID: 1649897
  36. Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle.
    J Gen Virol. 1991 Oct;72 ( Pt 10):2391-8 PMID: 1655954
  37. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
    Mol Cell Biol. 1991 Dec;11(12):6268-78 PMID: 1658629
  38. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10870-4 PMID: 1660153
  39. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10875-9 PMID: 1660154
  40. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    J Virol. 1992 Jan;66(1):122-31 PMID: 1309242
  41. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication.
    J Virol. 1992 Jan;66(1):489-95 PMID: 1309258
  42. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.
    EMBO J. 1992 Mar;11(3):1165-76 PMID: 1312463
  43. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines.
    Cancer. 1992 Jul 1;70(1):185-91 PMID: 1318776
  44. Identification of a site required for DNA replication fork blocking activity in the rRNA gene cluster in Saccharomyces cerevisiae.
    Mol Gen Genet. 1992 Jun;233(3):355-62 PMID: 1620093
  45. RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types.
    J Gen Virol. 1992 Jul;73 ( Pt 7):1687-92 PMID: 1321209
  46. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.
    J Virol. 1992 Aug;66(8):5030-9 PMID: 1321285
  47. The arrest of replication forks in the rDNA of yeast occurs independently of transcription.
    Cell. 1992 Oct 16;71(2):267-76 PMID: 1423594
  48. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    J Virol. 1993 Mar;67(3):1739-45 PMID: 8382320
  49. Identification and characterization of a complex chromosomal replication origin in Schizosaccharomyces pombe.
    Chromosoma. 1992;102(1 Suppl):S7-16 PMID: 1291242
  50. Conserved features in the mode of replication of eukaryotic ribosomal RNA genes.
    EMBO J. 1993 Apr;12(4):1475-85 PMID: 8467799
  51. Easily unwound DNA sequences and hairpin structures in the Epstein-Barr virus origin of plasmid replication.
    J Virol. 1993 May;67(5):2707-15 PMID: 8386273
  52. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors.
    J Virol. 1993 Jun;67(6):3217-25 PMID: 8098777
  53. cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus.
    J Virol. 1993 Jul;67(7):4237-45 PMID: 8389925
  54. Initiation and termination of DNA replication in human rRNA genes.
    Mol Cell Biol. 1993 Oct;13(10):6600-13 PMID: 8413256
  55. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.
    EMBO J. 1993 Dec 15;12(13):4933-44 PMID: 8262037
  56. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1.
    J Virol. 1994 Jun;68(6):4067-71 PMID: 8189545
  57. Epstein-Barr virus strategy in normal and neoplastic B cells.
    Cell. 1994 Jun 17;77(6):791-3 PMID: 8004668
  58. The replication terminator protein of the gram-positive bacterium Bacillus subtilis functions as a polar contrahelicase in gram-negative Escherichia coli.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11143-7 PMID: 7972025
  59. Human artificial episomal chromosomes for cloning large DNA fragments in human cells.
    Nat Genet. 1994 Sep;8(1):33-41 PMID: 7987390
  60. A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.
    J Clin Pathol. 1965 May;18:261-73 PMID: 14304234
  61. Synthesis of immunoglobulins by human cell lines in tissue culture.
    J Immunol. 1967 Nov;99(5):839-48 PMID: 4169031
  62. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
    Cancer Res. 1968 Jul;28(7):1300-10 PMID: 4174339
  63. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1972 Feb;69(2):383-7 PMID: 4333982
  64. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.
    Cell. 1980 Nov;22(1 Pt 1):257-67 PMID: 6253079
  65. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4251-5 PMID: 6933474
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1995-05-00
Pages
2893-903
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC230520
Subset
IM
Grants
NCI NIH HHS · P30-CA13330 · United States
NIGMS NIH HHS · R01 GM45751 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com